Cytomegalovirus Detection and Monitoring After Autologous Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Surveillance Strategies and Outcomes
Diagnostics · 20.11.2026 · 16 (22) · 3897
DOI: 10.3390/diagnostics16223897 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diagnostics, online erschienen am 20.11.2026. Verfasst von Felix Bratosin und 3 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babeș” University of Medicine and Pharmacy Timișoara.
Abstract (Originalsprache)
Background/Objectives: Reported cytomegalovirus (CMV) frequency after autologous haematopoietic stem cell transplantation (auto-HSCT) varies widely. We asked how much of that variation reflects how CMV is sought rather than how often it occurs and how often it causes disease.
Methods
PubMed, Europe PMC, Embase and Scopus were searched from inception to 12 September 2026. Reports of at least 20 predominantly adult autologous recipients with an extractable CMV outcome were eligible. Virological detection, symptomatic infection, antiviral-treated infection, confirmed end-organ disease and attributed death were pooled separately by random-effects meta-analysis and a binomial-normal mixed model, stratified by monitoring strategy, denominator, and whether the case definition required symptoms.
Results
Thirty-eight reports were included. Detection tracked ascertainment: 17.6% (95% confidence interval (CI) 12.7–23.9) under systematic surveillance, 3.9% (95% CI 1.0–14.4) under symptom-triggered testing, and 37.4% (95% CI 29.9–45.6) where the denominator was restricted to seropositive recipients. That difference disappeared once both arms were restricted to reports enumerating laboratory-detected CMV (2.7%; Q = 2.37, p = 0.12), an artefact of case definition. Clinical consequences were uncommon and stable across strategies: end-organ disease 1.8% (95% CI 1.2–2.7), confirmed disease 1.7% (95% CI 1.0–2.9), attributed death 0.8% (95% CI 0.5–1.2). Median first detection was 30–35 days. Heterogeneity was high for detection (I2 75–96%) and absent for death.
Conclusions
After auto-HSCT, how often CMV is reported depends mainly on who is tested and how infection is defined, while end-organ disease and attributed death remain uncommon under every strategy. These data support evaluating risk-adapted monitoring rather than universal surveillance.
Förderung
- “Victor Babeș” University of Medicine and Pharmacy Timișoara
Zitieren
APA
Bratosin, F., Stanga, L., Bogdan, I. G., & Pescariu, S. A. (2026). Cytomegalovirus Detection and Monitoring After Autologous Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Surveillance Strategies and Outcomes. Diagnostics, 16(22), 3897. https://doi.org/10.3390/diagnostics16223897
Vancouver
Bratosin F, Stanga L, Bogdan IG, Pescariu SA. Cytomegalovirus Detection and Monitoring After Autologous Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Surveillance Strategies and Outcomes. Diagnostics. 2026;16(22):3897. doi:10.3390/diagnostics16223897
BibTeX
@article{Bratosin2026,
author = {Bratosin, Felix and Stanga, Livia and Bogdan, Iulia Georgiana and Pescariu, Silvius Alexandru},
title = {Cytomegalovirus Detection and Monitoring After Autologous Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Surveillance Strategies and Outcomes},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {22},
pages = {3897},
doi = {10.3390/diagnostics16223897}
}
EUVIMED